A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies

Clinical trial NCT00523432 · COMPLETED

Trial details

NCT number: NCT00523432
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Genital Neoplasms, Female

Start date: 2007-08-01
Primary completion: 2009-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.